These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24814876)

  • 1. Role of epigenetic mechanisms in the development of chronic complications of diabetes.
    Wegner M; Neddermann D; Piorunska-Stolzmann M; Jagodzinski PP
    Diabetes Res Clin Pract; 2014 Aug; 105(2):164-75. PubMed ID: 24814876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The impact of chromatin modification on the development of chronic complications in patients with diabetes].
    Wegner M; Pioruńska-Stolzmann M; Jagodziński PP
    Postepy Hig Med Dosw (Online); 2015 Aug; 69():964-8. PubMed ID: 26400882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic mechanisms in diabetic complications and metabolic memory.
    Reddy MA; Zhang E; Natarajan R
    Diabetologia; 2015 Mar; 58(3):443-55. PubMed ID: 25481708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting epigenetic regulators for treating diabetic nephropathy.
    Kushwaha K; Garg SS; Gupta J
    Biochimie; 2022 Nov; 202():146-158. PubMed ID: 35985560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epigenetic regulation of podocyte function in diabetes.
    Majumder S; Advani A
    J Diabetes Complications; 2015; 29(8):1337-44. PubMed ID: 26344726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms.
    Intine RV; Sarras MP
    Curr Diab Rep; 2012 Oct; 12(5):551-9. PubMed ID: 22760445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic memory associated epigenetic changes.
    Siebel AL; Fernandez AZ; El-Osta A
    Biochem Pharmacol; 2010 Dec; 80(12):1853-9. PubMed ID: 20599797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes.
    Prattichizzo F; Giuliani A; Ceka A; Rippo MR; Bonfigli AR; Testa R; Procopio AD; Olivieri F
    Clin Epigenetics; 2015; 7(1):56. PubMed ID: 26015812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epigenetic landscape in the cardiovascular complications of diabetes.
    Costantino S; Ambrosini S; Paneni F
    J Endocrinol Invest; 2019 May; 42(5):505-511. PubMed ID: 30291588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic changes in diabetes.
    Keating ST; El-Osta A
    Clin Genet; 2013 Jul; 84(1):1-10. PubMed ID: 23398084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of epigenetic modification in higher brain dysfunction and aging].
    Ikegami D; Narita M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Nov; 32(5-6):275-80. PubMed ID: 23373315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modifications in metabolic memory: What are the memories, and can we erase them?
    Chen Z; Natarajan R
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C570-C582. PubMed ID: 35785987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics: deciphering its role in diabetes and its chronic complications.
    Villeneuve LM; Reddy MA; Natarajan R
    Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):451-9. PubMed ID: 21309809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic exposure, glycemic control, and metabolic karma in diabetic complications.
    Thomas MC
    Adv Chronic Kidney Dis; 2014 May; 21(3):311-7. PubMed ID: 24780460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics: mechanisms and implications for diabetic complications.
    Cooper ME; El-Osta A
    Circ Res; 2010 Dec; 107(12):1403-13. PubMed ID: 21148447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic retinopathy, metabolic memory and epigenetic modifications.
    Kowluru RA
    Vision Res; 2017 Oct; 139():30-38. PubMed ID: 28700951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions.
    Perrone L; Devi TS; Hosoya K; Terasaki T; Singh LP
    J Cell Physiol; 2009 Oct; 221(1):262-72. PubMed ID: 19562690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-independent persistence of PAI-1 gene expression and H3K4 tri-methylation in type 1 diabetic mouse endothelium: implication in metabolic memory.
    Takizawa F; Mizutani S; Ogawa Y; Sawada N
    Biochem Biophys Res Commun; 2013 Mar; 433(1):66-72. PubMed ID: 23454124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.